George H. Hitchings and Gertrude B. Elion
Level 5 - mechanism / opinion, no new human data
Historical biography and narrative profile without original empirical data (level assigned by non-clinical design analogy).
OpenAlex W3114913200 · doi:10.1093/eurheartj/ehaa124
What was done
This paper is a biographical and historical narrative detailing the careers and scientific achievements of George H. Hitchings and Gertrude B. Elion, focusing on their shift from trial-and-error drug discovery to rational drug design and their 1988 Nobel Prize in Physiology or Medicine.
What was found
The abstract reports no experimental numbers, trial data, or statistical metrics. It describes their foundational work demonstrating differential nucleic acid metabolism across cell types and pathogens, which led to the creation of 6-mercaptopurine, thioguanine, pyrimethamine, azathioprine, allopurinol, trimethoprim combinations, acyclovir, and later azidothymidine (AZT), as well as James Black's development of propranolol.
Why it matters
It highlights how understanding basic biochemical pathways and receptor physiology established the modern paradigm of rational drug discovery across oncology, virology, immunology, and cardiology.
Limits
This article is purely a historical commentary and biography. It presents no new clinical or experimental data, includes no systematic review methodology, and does not conduct quantitative analyses.
Cited by
- supports Gertrude Elion and George Hitchings won a Nobel Prize for developing nucleoside and nucleotide analogs as anticancer and antiviral drugs at Research Triangle Park.